Pathological response to neoadjuvant 5-FU, oxaliplatin and docetaxel (FLOT) versus epirubicin, cisplatin and 5-FU (ECF) in patients with locally advanced, resectable gastric/esophagogastric junction (EGJ) cancer: Data from the phase II part of the FLOT4 phase III study of the AIO

被引：1

作者：

Pauligk, C. ^{[1
]}

Tannapfel, A. ^{[2
]}

Meiler, J. ^{[3
]}

Luley, K. B. ^{[4
]}

Kopp, H. G. ^{[5
]}

Homann, N. ^{[6
]}

Hofheinz, R. D. ^{[7
]}

Schmalenberg, H. ^{[8
]}

Probst, S. ^{[9
]}

Haag, G. M. ^{[10
]}

Egger, M. ^{[11
]}

Behringer, D. M. ^{[12
]}

Stoehlmacher, J. ^{[13
]}

Prasnikar, N. ^{[14
]}

Block, A. ^{[15
]}

Trojan, J. ^{[16
]}

Folprecht, G. ^{[13
]}

Pohl, M. ^{[17
]}

Schirmacher, P. ^{[18
]}

Al-Batran, S. E. ^{[1
]}

机构：

[1] UCT Univ Canc Ctr, Krankenhaus Nordwest, Frankfurt, Germany

[2] Ruhr Univ Bochum, Inst Pathol, Bochum, Germany

[3] Univ Hosp Essen, Dept Med Oncol, Essen, Germany

[4] Med Clin I, Lubeck, Germany

[5] Univ Tubingen, Med Clin 2, Tubingen, Germany

[6] Acad Teaching Hosp Wolfsburg, Med Clin 2, Wolfsburg, Germany

[7] Univ Med Ctr Mannheim, Med Clin 3, Mannheim, Germany

[8] Univ Klinikum Jena, Clin Internal Med 2, Jena, Germany

[9] Klinikum Bielefeld, Clin Hematol & Oncol, Bielefeld, Germany

[10] Univ Heidelberg Hosp, Med Oncol, Heidelberg, Germany

[11] Ortenau Klinikum Lahr, Med Clin, Lahr, Germany

[12] Augusta Kranken Anstalt, Clin Hematol & Oncol, Bochum, Germany

[13] Univ Klinikum Carl Gustav Carus, Med Clin & Policlin 1, Dresden, Germany

[14] Klinikum Ludwigsburg, Med Clin 1, Ludwigsburg, Germany

[15] Univ Hosp Hamburg Eppendorf, Dept Hematol & Oncol, Hamburg, Germany

[16] Goethe Univ Frankfurt, Med Clin 1, D-60054 Frankfurt, Germany

[17] Ruhr Univ Bochum, Dept Internal Med, Bochum, Germany

[18] Univ Heidelberg Hosp, Dept Pathol, Heidelberg, Germany

来源：

EUROPEAN JOURNAL OF CANCER | 2015年 / 51卷

关键词：

D O I：

10.1016/S0959-8049(15)30080-0

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

36LBA

引用

页码：S728 / S728

页数：1